Previct Alcohol — the digital future of dependency treatment

Alcohol abuse is a major problem in today’s society.  In Sweden, the cost of alcohol-related injuries and treatment amounts to SEK 100 billion per year. This illness is not only costly to society as a whole, but also causes great suffering for addicts and their loved ones.

The team at Kontigo Care wants to free people from the harmful effects of dependency and addiction. Previct Alcohol is a digital medical device for enhanced drug rehabilitation.

The system uses patent-pending digital biomarkers to identify relapses at an early stage and provides complementary support, regardless of treatment method. The caregiver receives real-time notifications of anomalies in the patient’s behavior and any lack of compliance to the treatment plan. Because of this, the caregiver is able to take action and make adjustments at a very early stage.

The patient is free to receive the majority of his/her treatment in the comfort of his/her own home and is motivated to make positive behavioral changes for long-term results. Also, the patient is safe in the knowledge that the caregiver monitors his/her status in real-time and intervenes in case of a relapse.

The system’s unique digital biomarkers help health professionals detect upcoming relapses early. It was traditional biomarkers that provided the basis for today’s modern successful cancer treatment; now we have created digital biomarkers for a successful treatment of addictive disorders. Therapy takes place on the patient’s terms and is, to a large extent, integrated into the patient’s everyday life. By directly involving the patient in the process, the chances of long-term and cost-effective results increase significantly.